KLP Kapitalforvaltning AS Boosts Stake in Humana Inc. $HUM

KLP Kapitalforvaltning AS lifted its stake in Humana Inc. (NYSE:HUM) by 5.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 46,070 shares of the insurance provider’s stock after purchasing an additional 2,400 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Humana were worth $11,835,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the stock. OVERSEA CHINESE BANKING Corp Ltd bought a new stake in shares of Humana in the 4th quarter worth approximately $272,000. Evergreen Capital Management LLC boosted its position in shares of Humana by 145.0% in the 4th quarter. Evergreen Capital Management LLC now owns 2,288 shares of the insurance provider’s stock worth $588,000 after purchasing an additional 1,354 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Humana by 56.0% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 84,695 shares of the insurance provider’s stock worth $21,693,000 after purchasing an additional 30,402 shares in the last quarter. Krilogy Financial LLC boosted its position in shares of Humana by 25.2% in the 4th quarter. Krilogy Financial LLC now owns 1,963 shares of the insurance provider’s stock worth $518,000 after purchasing an additional 395 shares in the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. boosted its position in shares of Humana by 5.9% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,335 shares of the insurance provider’s stock worth $1,110,000 after purchasing an additional 242 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on HUM. Leerink Partners dropped their price target on Humana from $267.00 to $185.00 and set a “market perform” rating on the stock in a research report on Thursday, February 12th. Barclays dropped their price target on Humana from $245.00 to $176.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 24th. Royal Bank Of Canada cut Humana from an “outperform” rating to a “sector perform” rating and dropped their price target for the stock from $322.00 to $189.00 in a research report on Thursday, February 12th. Wells Fargo & Company upped their price objective on Humana from $206.00 to $227.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 7th. Finally, Guggenheim lowered their price objective on Humana from $312.00 to $252.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. Seven analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus target price of $222.09.

Humana Price Performance

Shares of HUM opened at $214.85 on Friday. The firm has a market cap of $25.79 billion, a PE ratio of 21.88, a P/E/G ratio of 2.33 and a beta of 0.44. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. The firm has a fifty day simple moving average of $184.01 and a two-hundred day simple moving average of $229.67. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $315.35.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. The business had revenue of $32.64 billion during the quarter, compared to analyst estimates of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company’s quarterly revenue was up 11.3% compared to the same quarter last year. During the same period in the previous year, the business earned ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities analysts anticipate that Humana Inc. will post 9.05 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.6%. Humana’s payout ratio is currently 36.05%.

Insiders Place Their Bets

In related news, insider Sanjay K. Shetty bought 810 shares of the firm’s stock in a transaction on Monday, February 23rd. The stock was acquired at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the purchase, the insider owned 11,657 shares in the company, valued at approximately $2,158,992.97. This represents a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.20% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.